Employees: 11-50
Total raised: $20M
Founded date: 2000
Investors 1
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.08.2012 | - | $20M | - |
Mentions in press and media 7
| Date | Title | Description |
| 12.03.2024 | MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology | - |
| 12.01.2023 | MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatment of Recurrent and Newly Diagnosed Glioblastoma | Preliminary results will be presented at the 20th Annual World Congress of the Society for Brain Mapping and Therapeutics /EIN News/ -- LA JOLLA, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded... |
| 21.04.2022 | MediciNova to Participate in the B. Riley Neuro & Ophthalmology Conference | LA JOLLA, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that ... |
| 29.06.2021 | MediciNova to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference | LA JOLLA, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Y... |
| 22.04.2021 | MEDICINOVA, INC. MediciNova Receives Gene Therapy Milestone Payments | LA JOLLA, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that ... |
| 09.03.2021 | MediciNova Announces Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury | LA JOLLA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it ha... |
| 21.08.2012 | MediciNova Raises $20M | Publicly held biopharmaceuticals firm MediciNova, which is based in San Diego, said last night that it has raised $20M in funding in a deal with Aspire Capital Fund, LLC. Medicinova said that Aspire will purchase the $20M in common stock at... |